troloxoyl sh-pentapeptide-12 sp est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety opinion located, and no peer-reviewed reproductive toxicity or human pregnancy data found for Troloxoyl SH‑pentapeptide‑12. As a peptide conjugate with no evidence of systemic reproductive toxicity, default scoring is 0 for hazard and mechanism; expected dermal absorption from topical cosmetic use is negligible (peptides are large/polar), so exposure scored 0. Sources checked: ECHA Annex VI (no entry), SCCS/CIR (no assessment), PubMed (no relevant reproductive studies), CosIng/PubChem (ingredient listing only).
Related ingredients
Frequently asked questions
- troloxoyl sh-pentapeptide-12 sp est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety opinion located, and no peer-reviewed reproductive toxicity or human pregnancy data found for Troloxoyl SH‑pentapeptide‑12. As a peptide conjugate with no evidence of systemic reproductive toxicity, default scoring is 0 for hazard and mechanism; expected dermal absorption from topical cosmetic use is negligible (peptides are large/polar), so exposure scored 0. Sources checked: ECHA Annex VI (no entry), SCCS/CIR (no assessment), PubMed (no relevant reproductive studies), CosIng/PubChem (ingredient listing only).
- troloxoyl sh-pentapeptide-12 sp est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no harmonised classifications or authoritative safety assessments indicating reproductive or lactation risk; no data demonstrating mammary transfer or effects on lactation. Topical peptide conjugates are expected to have negligible systemic availability under normal cosmetic use.
- troloxoyl sh-pentapeptide-12 sp est-il sûr pour la peau de bébé ?
- No infant-specific data were identified. Peptide conjugates are generally large molecules with low skin penetration, so exposure for babies (0–3 yr) is assessed as negligible in absence of absorption data. Per instruction, baby exposure was not increased because adult exposure is considered negligible and no data indicate measurable absorption.
- Comment VeriMom évalue-t-il troloxoyl sh-pentapeptide-12 sp ?
- VeriMom évalue troloxoyl sh-pentapeptide-12 sp à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à troloxoyl sh-pentapeptide-12 sp pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à troloxoyl sh-pentapeptide-12 sp basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.